Premenstrual dysphoric disorder: Current status of treatment

Swiss Medical Weekly

Volumn 132, Issue 39-40, 2002, Pages 574-578

  Bianchi Demicheli, Francesco ^a   Lüdicke, Frank ^a   Lucas, Hervé ^a   Chardonnens, Didier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Premenstrual dysphoric disorder; Premenstrual syndrome

Indexed keywords

MINERAL; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; DAILY LIFE ACTIVITY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HUMAN RELATION; LUTEAL PHASE; MENSTRUAL CYCLE; MENSTRUATION; OVULATION; PHYSICAL ACTIVITY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; RECURRENT DISEASE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0037010508     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Kaplan HI, Saddock BJ. Synopsis of Psychiatry. Baltimore: Williams & Wilkins,; 1997.
2. DSM-IV Diagnostic and Statistical Manual of Mental Disorders. Paris: Masson;1996.
3. Pearlstein T, Stone AB. Premenstrual syndrome. Psychiatr. Clin. North Am 1998;21:577-90.
4. Mimoun S. Traité de gynécologic-obstétrique psychosomatique. Paris: Masson;1999.
5. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract:prospective, randomised, placebo controlled study. BMJ 2001;322:134-7.
6. Limosin F, Ades J. Psychiatric and psychological aspects of premenstrual syndrome. Encephale 2001;27:501-8.
7. Johnson SR. Premenstrual syndrome therapy. Clin Obstet Gynecol 1998;41:405-21.
8. Aganoff JA, Boyle GJ. Aerobic exercise, mood states and menstrual cycle symptoms. J Psychosom Res 1994;38:183-92.
9. Wurtman JJ, Brzezinski A, Wurtman RJ, Laferrere B. Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol 1989;161:1228-34.
10. Penland JG, Johnson PE. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol 1993;168:1417-23.
11. Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome:effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998;179:444-52.
12. Facchinetti F, Borella P, Sances G, Fioroni L, Nappi RE, Genazzani AR. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 1991;78:177-81.
13. London RS, Sundaram GS, Murphy L, Goldstein PJ. The effect of alpha-tocopherol on premenstrual symptomatology:a double-blind study. J Am Coll. Nutr. 1983;2:115-22.
14. London RS, Murphy L, Kitlowski KE, Reynolds MA. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J Reprod Med 1987;32:400-4.
15. Kleijnen J, Ter Riet G, Knipschild P. Vitamin B6 in the treatment of the premenstrual syndrome - a review. Br J Obstet Gynaecol 1990;97:847-52.
16. Freeman EW, Sondheimer SJ, Rickels K. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria:a controlled study. Psychopharmacol. Bull 1997;33:303-9.
17. Deeny M, Hawthorn R, McKay HD. Low dose danazol in the treatment of the premenstrual syndrome. Postgrad. Med J 1991;67:450-4.
18. Gilmore DH, Hawthorn RJ, Hart DM. Danol for premenstrual syndrome:a preliminary report of a placebo-controlled double-blind study. J Int. Med Res. 1985;13:129-130.
19. Sarno AP, Jr., Miller EJ, Jr., Lundblad EG. Premenstrual syndrome: beneficial effects of periodic, low-dose danazol. Obstet Gynecol 1987;70:33-6.
20. Watts JF, Edwards RL, Butt WR. Treatment of premenstrual syndrome using danazol:preliminary report of a placebo-controlled, double-blind, dose ranging study. J Int. Med Res. 1985;13:127-8.
21. Watts JF, Butt WR, Logan ER. A clinical trial using danazol for the treatment of premenstrual tension. Br J Obstet Gynaecol 1987;94:30-4.
22. Menkes DB, Taghavi E, Mason PA, Spears GF, Howard RC. Fluoxetine treatment of severe premenstrual syndrome. BMJ 1992;305:346-7.
23. Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994;55:332-5.
24. Pearlstein TB, Stone AB, Lund SA, Scheft H, Zlotnick C, Brown WA. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin. Psychopharmacol. 1997;17:261-6.
25. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med 1995;332:1529-34.
26. Stewart DE, Fairman M, Barbadoro S, Zownir P, Steiner M. Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder. Biol Psychiatry 1994;36:201-2.
27. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of premenstrual syndrome. Psychopharmacol. Bull 1990;26:331-5.
28. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin. Psychiatry 1991;52:290-3.
29. Su TP, Schmidt PJ, Danaceau MA, Tobin MB, Rosenstein DL, Murphy DL, Rubinow DR. Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology 1997;16:346-56.
30. Freeman EW, Rickels K, Sondheimer SJ, Wittmaack FM. Sertraline versus desipramine in the treatment of premenstrual syndrome:an open-label trial. J Clin. Psychiatry 1996;57:7-11.
31. Freeman EW, Rickels K, Sondheimer SJ, Polansky M. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder:a randomized controlled trial. Arch. Gen. Psychiatry 1999;56:932-9.
32. Halbreich U, Smoller JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 1997;58:399-402.
33. Young SA, Hurt PH, Benedek DM, Howard RS. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase:a randomized, double-blind, placebo-controlled crossover trial. J Clin Psychiatry 1998;59:76-80.
34. Sundblad C, Wikander I, Andersch B, Eriksson E. A naturalistic study of paroxetine in premenstrual syndrome:efficacy and side-effects during ten cycles of treatment. Eur Neuropsychopharmacol. 1997;7:201-6.
35. Yonkers KA, Gullion C, Williams A, Novak K, Rush AJ. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol 1996;16:3-8.
36. Eriksson E, Hedberg MA, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995;12:167-76.
37. Mortola JF. A risk-benefit appraisal of drugs used in the management of premenstrual syndrome. Drug Saf 1994;10:160-9.
38. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson F, Eriksson E. Citalopram in premenstrual dysphoria:is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 1998;18:390-398.
39. Daamen MJ, Brown WA. Single-dose fluoxetine in management of premenstrual syndrome. J Clin. Psychiatry 1992;53:210-1.
40. Steiner M, Korzekwa M, Larnont J, Wilkins A. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol. Bull 1997;33:771-4.
41. Freeman EW, Rickels K, Yonkers KA, Kunz NR, McPherson M, Upton GV. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol 2001;98:737-44.
42. Evans SM, Haney M, Levin FR, Foltin RW, Fischman MW. Mood and performance changes in women with premenstrual dysphoric disorder:acute effects of alprazolam. Neuropsychopharmacology 1998;19:499-516.
43. Rickels K, Freeman E, Sondheimer S. Buspirone in treatment of premenstrual syndrome. Lancet 1989/I:777.
44. Morse CA, Dennerstein L, Farrell E, Varnavides K. A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome. J Behav Med 1991;14:469-89.
45. Blake F, Salkovskis P, Gath D, Day A, Garrod A. Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom. Res. 1998;45:307-18.
46. Christensen AP, Oei TP. The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes. J Affect. Disord. 1995;33:57-63.
47. Sampson GA, Heathcote PR, Wordsworth J, Prescott P, Hodgson A. Premenstrual syndrome. A double-blind cross-over study of treatment with dydrogesterone and placebo. Br J Psychiatry 1988;153:232-5.
48. True BL, Goodner SM, Burns EA. Review of the etiology and treatment of premenstrual syndrome. Drug Intell Clin Pharm 1985;19:714-22.
49. Magos AL, Brincat M, Studd JW. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study. Br Med J (Clin Res Ed) 1986;292:1629-33.
50. Freeman EW, Rickels K. Characteristics of placebo responses in medical treatment of premenstrual syndrome. Am J Psychiatry 1999;156:1403-8.
51. Papiernik E, Rozembaum H, Belaisch-Allart J. Gynécologie. Paris: Flammarion; 1990.
52. Ackermann RT, Williams JW, Jr. Rational treatment choices for non-major depressions in primary care: an evidence-based review. J Gen. Intern. Med 2002;17:293-301.
53. Dimmock PW, Wyatt KM, Jones PW, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;356:1131-6.